7loi
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==Model of the HIV-1 gp41 membrane-proximal external region, transmembrane domain and cytoplasmic tail== | ==Model of the HIV-1 gp41 membrane-proximal external region, transmembrane domain and cytoplasmic tail== | ||
| - | <StructureSection load='7loi' size='340' side='right'caption='[[7loi]]' scene=''> | + | <StructureSection load='7loi' size='340' side='right'caption='[[7loi]], [[NMR_Ensembles_of_Models | 15 NMR models]]' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>Full | + | <table><tr><td colspan='2'>[[7loi]] is a 3 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7LOI OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7LOI FirstGlance]. <br> |
</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7loi FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7loi OCA], [https://pdbe.org/7loi PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7loi RCSB], [https://www.ebi.ac.uk/pdbsum/7loi PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7loi ProSAT]</span></td></tr> | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7loi FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7loi OCA], [https://pdbe.org/7loi PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7loi RCSB], [https://www.ebi.ac.uk/pdbsum/7loi PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7loi ProSAT]</span></td></tr> | ||
</table> | </table> | ||
| + | == Function == | ||
| + | [[https://www.uniprot.org/uniprot/A0A386YSI0_9HIV1 A0A386YSI0_9HIV1]] Envelope glycoprotein gp160: Oligomerizes in the host endoplasmic reticulum into predominantly trimers. In a second time, gp160 transits in the host Golgi, where glycosylation is completed. The precursor is then proteolytically cleaved in the trans-Golgi and thereby activated by cellular furin or furin-like proteases to produce gp120 and gp41.[HAMAP-Rule:MF_04083] Surface protein gp120: Attaches the virus to the host lymphoid cell by binding to the primary receptor CD4. This interaction induces a structural rearrangement creating a high affinity binding site for a chemokine coreceptor like CXCR4 and/or CCR5. Acts as a ligand for CD209/DC-SIGN and CLEC4M/DC-SIGNR, which are respectively found on dendritic cells (DCs), and on endothelial cells of liver sinusoids and lymph node sinuses. These interactions allow capture of viral particles at mucosal surfaces by these cells and subsequent transmission to permissive cells. HIV subverts the migration properties of dendritic cells to gain access to CD4+ T-cells in lymph nodes. Virus transmission to permissive T-cells occurs either in trans (without DCs infection, through viral capture and transmission), or in cis (following DCs productive infection, through the usual CD4-gp120 interaction), thereby inducing a robust infection. In trans infection, bound virions remain infectious over days and it is proposed that they are not degraded, but protected in non-lysosomal acidic organelles within the DCs close to the cell membrane thus contributing to the viral infectious potential during DCs' migration from the periphery to the lymphoid tissues. On arrival at lymphoid tissues, intact virions recycle back to DCs' cell surface allowing virus transmission to CD4+ T-cells.[HAMAP-Rule:MF_04083] Transmembrane protein gp41: Acts as a class I viral fusion protein. Under the current model, the protein has at least 3 conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During fusion of viral and target intracellular membranes, the coiled coil regions (heptad repeats) assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of viral and target cell membranes. Complete fusion occurs in host cell endosomes and is dynamin-dependent, however some lipid transfer might occur at the plasma membrane. The virus undergoes clathrin-dependent internalization long before endosomal fusion, thus minimizing the surface exposure of conserved viral epitopes during fusion and reducing the efficacy of inhibitors targeting these epitopes. Membranes fusion leads to delivery of the nucleocapsid into the cytoplasm.[HAMAP-Rule:MF_04083] | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | HIV-1 envelope glycoprotein (Env) is a transmembrane protein that mediates membrane fusion and viral entry. The membrane-interacting regions of the Env, including the membrane-proximal external region (MPER), the transmembrane domain (TMD), and the cytoplasmic tail (CT), not only are essential for fusion and Env incorporation but also can strongly influence the antigenicity of the Env. Previous studies have incrementally revealed the structures of the MPER, the TMD, and the KS-LLP2 regions of the CT. Here, we determined the NMR structure of the full-length CT using a protein fragment comprising the TMD and the CT in bicelles that mimic a lipid bilayer, and by integrating the new NMR data and those acquired previously on other gp41 fragments, we derived a model of the entire membrane-interacting region of the Env. The structure shows that the CT forms a large trimeric baseplate around the TMD trimer, and by residing in the headgroup region of the lipid bilayer, the baseplate causes severe exclusion of lipid in the cytoleaflet of the bilayer. All-atom molecular dynamics simulations showed that the overall structure of the MPER-TMD-CT can be stable in a viral membrane and that a concerted movement of the KS-LLP2 region compensates for the lipid exclusion in order to maintain both structure and membrane integrity. Our structural and simulation results provide a framework for future research to manipulate the membrane structure to modulate the antigenicity of the Env for vaccine development and for mutagenesis studies for investigating membrane fusion and Env interaction with the matrix proteins. | ||
| + | |||
| + | NMR Model of the Entire Membrane-Interacting Region of the HIV-1 Fusion Protein and Its Perturbation of Membrane Morphology.,Piai A, Fu Q, Sharp AK, Bighi B, Brown AM, Chou JJ J Am Chem Soc. 2021 Apr 21. doi: 10.1021/jacs.1c01762. PMID:33882664<ref>PMID:33882664</ref> | ||
| + | |||
| + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
| + | </div> | ||
| + | <div class="pdbe-citations 7loi" style="background-color:#fffaf0;"></div> | ||
| + | == References == | ||
| + | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
| - | [[Category: Bighi B]] | + | [[Category: Bighi, B]] |
| - | [[Category: Brown | + | [[Category: Brown, A M]] |
| - | [[Category: Chou | + | [[Category: Chou, J J]] |
| - | [[Category: Fu Q]] | + | [[Category: Fu, Q]] |
| - | [[Category: Piai A]] | + | [[Category: Piai, A]] |
| - | [[Category: Sharp | + | [[Category: Sharp, A K]] |
| + | [[Category: Ct]] | ||
| + | [[Category: Cytoplasmic tail]] | ||
| + | [[Category: Membrane protein]] | ||
| + | [[Category: Membrane-proximal external region]] | ||
| + | [[Category: Mper]] | ||
| + | [[Category: Tmd]] | ||
| + | [[Category: Transmembrane domain]] | ||
Revision as of 09:14, 5 May 2021
Model of the HIV-1 gp41 membrane-proximal external region, transmembrane domain and cytoplasmic tail
| |||||||||||
